Background: The pro-oncogenic transcription factor STAT3 is constitutively active in tumours of many different origins, which often become addicted to its activity. STAT3 is believed to contribute to the initial survival of pre-cancerous cells as well as to hyper-proliferation and, later, metastasis.
Introduction
STAT3, a member of the signal transducers and activators of transcription (STAT) family, is constitutively activated by phosphorylation on tyrosine 705 (Y-P) in a high percentage of tumours and tumour-derived cell lines of both liquid and solid origin. This factor is activated downstream of cytokines, growth factors and oncogenes including c-Src, EGFR and ErbB-2 [1] . STAT3 can also be phosphorylated on serine 727 (S-P) upon a number of stimuli leading to the activation of MAP kinases including Ras signalling [2] . Tumour cells often become addicted to STAT3, as interference with its transcriptional activity often triggers growth arrest and/or cell death. Indeed, STAT3 is required for cell transformation downstream of several oncogenes, the prototype being v-Src [3] , which triggers STAT3 Y-P. Recently, STAT3 S-P induced by activated Ras was shown to trigger tumour transformation, driving STAT3 to localise to mitochondria and regulate cellular respiration [4, 5] . This non-canonical activity is required for Ras-dependent oncogenic transformation. Thus, STAT3 appears to play a central role in mediating tumour transformation downstream of many different oncogenes and growth factors, via both canonical transcriptional functions and noncanonical, non-nuclear activities.
The pro-oncogenic role of STAT3 in vivo is underlined by the ability of its constitutively active mutant form STAT3C [6] to enhance the malignant progression of skin tumours or to trigger the onset of lung adenocarcinomas [7] when overexpressed. STAT3 can contribute to tumorigenesis by enhancing tumour cell proliferation and survival, down-modulating anti-tumour immune responses, promoting angiogenesis and inducing cell movement and epithelial to mesenchymal transition (EMT) [8] . Moreover, it is considered one of the main factors mediating infl ammation-induced cancer downstream of autocrine or paracrine production of IL-6 [9] . However, the mechanisms underlying in vivo STAT3 pro-oncogenic functions and the addiction of tumour cells are still incompletely understood. The STAT3-mediated gene expression signature varies in different tumour types, and many of its known pro-proliferative or anti-apoptotic target genes have been identifi ed upon acute stimulation and are not consistently induced in tumours displaying lower but continuous STAT3 Y-P, which suggests distinct subsets of target genes.
We have recently generated knock-in mice in which a mutant Stat3C allele replaces the wild-type endogenous gene [10] . These mice display low but continuous STAT3 activity that is reminiscent of that observed in most STAT3-dependent tumour cells, and they represent a good model to assess STAT3 in vivo pro-oncogenic activities. Here, we present and discuss some of the most signifi cant results. In particular, we show that STAT3 enhances tumour cell motility and invasion via a novel target gene, Cten, which represents a point of convergence with EGFR/HER2 signalling. Moreover, we discuss data showing that STAT3 acts as a master regulator of glucose metabolism and cellular respiration and that its inhibition leads to apoptotic death of STAT3-dependent cancer cells, at least partly via modifying their metabolic requirements [11] .
Results

Stat3C mice display constitutive STAT3 nuclear localisation, Y-P and transcriptional activity
The Stat3C allele was expressed at physiological levels in all tissues analysed [10] . Stat3 C/C mice died at a young age upon developing auto-immune myocarditis (A.C. and V.P., manuscript in preparation), whereas heterozygous Stat3 C/WT mice were viable and fertile. STAT3C was indeed weekly constitutively active and showed slightly enhanced nuclear loca lization, Y-P and transcriptional activity in several tissues. Moreover, Y-P and nuclear localisation were prolonged in mouse embryonic fi broblasts (MEFs) or in the liver of Stat3 C/C mice upon LPS or IL-6 treatment, respectively [10] . Both the transcriptional activity and DNA binding affi nity of the STAT3C protein were comparable to those of the wild-type form, as judged by similar induction levels of tested target genes and by EMSA competitions (not shown). The slightly increased basal activity of STAT3C and its prolonged activation upon cytokine stimulation suggest a lower activation threshold and represent an ideal model to investigate STAT3 oncogenic functions in vivo.
STAT3C expression enhances Neu-mediated mammary gland tumorigenesis
Spontaneous tumour onset could not be assessed in ageing Stat3 C/C mice due to their early mortality. No preneoplastic lesions or spontaneously arising tumours were detected in heterozygous Stat3 C/WT mice up to 24 months of age, and mammary gland morphology was normal in virgin, pregnant and lactating Stat3 C/WT female mice (I.B. and V.P., unpublished results). We therefore decided to assess potential cooperation with the Neu oncogene in mammary tumorigenesis in heterozygosity. MMTV-Neu transgenic mice (NeuT), which develop multiple foci of atypical hyperplasia progressing to invasive metastasizing carcinoma by 22 -27 weeks, were intercrossed with Stat3 C/WT mice to obtain NeuT,
WT/WT (N-WT) mice [10] . N-C mice developed palpable tumours signifi cantly earlier than their N-WT control littermates (Figure 1 A, p = 0.0014). N-C tumours showed normal proliferation rates, as assessed by PCNA staining, but sensibly reduced TUNEL-positive apoptotic nuclei (not shown). The main biochemical pathways involved in Neu-mediated mammary tumorigenesis were unaffected (data not shown). Three independent cell lines were derived from tumours of each genotype and named C or WT 1, 2 or 3. All three C cell lines displayed increased nuclear, phosphorylated STAT3, which suggests enhanced activity of the Stat3C allele. However, no signifi cant differences were detected in Pten, Akt, Gsk3-β , Src and Erk expression or activation levels (not shown). Likewise, C and WT cell lines did not differ signifi cantly in terms of proliferation or resistance to starvationmediated apoptosis (data not shown). These results are not surprising, although they are in apparent contradiction with the observed reduced apoptotic index of the N-C tumours, as in vitro stabilisation of tumour cells involves the selection of cells able to survive and can thus mask original features. In contrast, marked differences in cell morphology and cell contact organization were evident. All WT cell lines displayed a well differentiated epithelial phenotype growing in tight islets with well organised and continuous adherent and tight junctions, as shown by staining of E-Cadherin, β -Catenin and Zonula occludens-1 (Zo-1) ( Figure 1B) . Accordingly, actin fi bres were primarily located in the cortical region. In contrast, despite similar expression levels detected by Western blot (not shown), all C cell lines displayed discontinuous E-Cadherin, β -Catenin and Zo-1 distribution, reduced cortical actin and evident actin stress-fi bres that were not detected in the WT cells ( Figure 1B ).
Migration and extra-cellular matrix invasion of the C and WT cell lines were assessed by Transwell assays with or without a Matrigel coating (Figure 2 A) . Migration was at least doubled in all C cell lines (p = 0.0013), which also showed signifi cantly enhanced Matrigel invasion potential (p = 0.03). These results suggest higher invasive and metastatic activity. To evaluate these parameters in vivo, C1 or WT1 cells were injected intravenously into nude mice, and the formation of lung metastases was assessed after 3 or 5 weeks of injection. C1 cells produced signifi cantly more and faster growing lung metastases ( Figure 2B ). Similar results were obtained with the other cell lines (not shown). C1 cells were also able to produce subcutaneous tumours displaying fast and regular growth and reaching 10-mm diameters after 5 weeks, whereas tumours produced by the WT1 cells grew much slower and never reached a 10-mm size (not shown).
Cten is a novel STAT3 target gene partly mediating cell contact disruption and enhanced migration
Gene expression profi les of all cell lines were compared using an Illumina microarray platform. The " rank products " function was used to produce a list of 23 up-regulated genes, most of which were functionally related to growth control and/or tumour biology [10] . Consistent differential expression was confi rmed for Cten/tensin 4, Galectin 3 (Lgals3), Twist1, Lypd3 (ly6/Plaur domain containing 3) and Proliferin 2. In addition, both Cten and Twist 1 also displayed signifi cantly higher expression in the N-C tumours as compared to their N-WT controls (not shown).
Cten, the most consistently up-regulated gene, has been shown to be implicated in EGF-dependent mammary cell migration [12] . We therefore decided to assess its contribution to the observed phenotype of the C cell lines. siRNA treatment could effi ciently reduce Cten levels to about 20 % in both the C1 and C2 cell lines (not shown), resulting in signifi cant inhibition of cell migration (Figure 3 A) and, intriguingly, in partial reversion of both Zo-1 and β -Catenin cell surface distribution ( Figure 3B ). Cells adopted a more epithelial phenotype and displayed enhanced and more continuous cortical localisation of both epithelial markers, which correlates with tighter cellcell contact, as evident in the phase-contrast images.
Both Cten overexpression and increased cell migration were indeed dependent on Stat3 activity, as treatment of C1 cells with the specifi c Stat3 inhibitor S3I coordinately and strongly reduced Stat3 phosphorylation, Cten levels and cell migration ( Figure 3C ). In addition, we observed that IL-6 treatment could effi ciently upregulate Cten in MCF10 human mammary cells in a STAT3-dependent manner [10] .
STAT3 constitutive activation elicits pre-oncogenic features in Stat3 C/C MEFs
We sought then to assess whether primary Stat3 C/C MEFs displayed pre-oncogenic or transformed features [11] . Stat3 C/C cells grew faster than their wild-type controls and displayed an accelerated cell cycle, with a more rapid transit through S-phase (not shown). Despite growing in monolayer, they reached higher cell density at confl uence and were highly resistant to apoptosis induced by different stimuli, such as H 2 O 2 treatment (20 % of apoptotic cells after 16 h, compared to 85 % in the wild-type controls, Figure 4 A), serum starvation and UV treatment [11] . Moreover, showed a strong delay in spontaneous senescence, as shown by β -galactosidase staining 3 and 6 weeks post-confl uence ( Figure 4B ). Whereas all Stat3
WT/WT cells were dead by 6 weeks, Stat3 C/C cells began to show β -gal positivity but were able to survive and resume proliferation when passaged.
Stat3C induces a metabolic switch to aerobic glycolysis in primary MEFs
Gene expression profi ling revealed about 1000 differentially expressed genes between Stat3 C/C and Stat3 WT/WT MEFs. Many of the down-regulated genes in the Stat3 C/C cells belonged to gene ontology (GO) categories related to mitochondrial function (not shown). Conversely, several genes involved in glycolysis were highly expressed in the Stat3 C/C cells, including the hypoxia inducible factor (Hif)-1 α and the pyruvate dehydrogenase kinase (Pdk)-1, the glucose transporter Glut-1 and two key enzymes, phospho-fruktokinase L-type (Pfk-L) and enolase-1 (Eno-1), all of which are known HIF-1 α target genes (Figure 5 A) . Accordingly, Stat3 C/C cells exhibited a glycolytic phenotype, producing higher amounts of lactate and consuming more glucose ( Figure 5B ), and they were highly sensitive to glucose deprivation as compared to their wild-type controls, as shown by both cultivating cells in a glucose-free medium and by treatment with the glucose analog 2-DG [11] . WT/WT cells were all dead at 6 weeks. Modifi ed from reference [11] . Hif-1 α silencing normalised the glycolytic metabolism of Stat3 C/C MEFs, which led to down-regulation of Pdk-1, Glut-1, Pfk-L and Eno-1 mRNAs, but not of the glycolysis-unrelated STAT3 target Socs3 ( Figure 5C ). Accordingly, lactate production, glucose intake and sensitivity to glucose deprivation were strongly reduced ( Figure 5D and not shown). Thus, the expression of STAT3C, which mimics the constitutive STAT3 activation observed in many tumours, is suffi cient to promote aerobic glycolysis, acting at least in part through the transcriptional induction of HIF-1 α .
Reduced mitochondrial activity in Stat3
C/C MEFs Stat3 C/C MEFs exhibited a signifi cant down-regulation of nuclear-encoded genes involved in mitochondrial function, which correlates with reduced protein levels of representative components of the electron transport chain (ETC), particularly those belonging to complexes IV and V (Figure 6 A) . This observation suggests potentially reduced cellular respiration, similar to what was observed in cancer cells displaying aerobic glycolysis and the Warburg effect. We thus assessed both mitochondrial-specifi c Ca 2 + uptake, which directly regulates oxidative phosphorylation, and mitochondrial ATP production. Stat3 C/C MEFs indeed showed reduced mitochondrial Ca 2 + uptake upon ATP stimulation ( Figure  6B ). Accordingly, both mitochondrial ATP production and basal respiratory chain activity were reduced ( Figures 6C  and 6D ), which correlated with lowered maximal respiratory chain activity measured in the uncoupled state ( Figures 6E) . Importantly, the reduced mitochondrial activity was STAT3-dependent but could not be rescued by Hif-1 α silencing (not shown), which suggests that constitutively active STAT3 regulates aerobic glycolysis and cellular respiration via two distinct mechanisms.
STAT3-dependent glycolysis contributes to in vitro and in vivo survival of cancer cell lines addicted to STAT3 activity
Our data suggest that constitutively active STAT3 can act as a central mediator of aerobic glycolysis, which would explain the general STAT3 addiction of cancer cells. To test this idea, we assessed the effects of inhibiting STAT3 on the glycolytic metabolism and mitochondrial activity of the STAT3-dependent epithelial tumour cell line MDA-MB468. Inhibition of STAT3 activity with the S3I compound dramatically lowered Hif-1 α and Pdk-1 expression and decreased lactate production (Figure 7 A) , while rescuing mitochondrial-Ca 2 + uptake at the same time [ Figure 7B ). Similar observations were obtained with other two STAT3-dependent cell lines (DU145 and SKBR3). STAT3 inhibition did not have any effects on the control cancer cell line T47D, which does not display constitutive STAT3 activity and, accordingly, does not depend on STAT3 for survival (data not shown). Thus, tumour cell lines that display constitutive STAT3 Y-P and are dependent on STAT3 for survival exhibit a strictly STAT3-dependent aerobic glycolytic phenotype, comparable to that observed in the Stat3 C/C MEFs. To confi rm the fundamental role of STAT3 in regulating the glycolytic switch of STAT3-dependent tumour cells in vivo, we measured the glucose uptake of xenografted MDA-MB468 tumours in the presence or absence of S3I treatment by means of PET analysis, using the radioactive glucose-analogue 18 F-FDG (PET-FDG, Figure 7C ). S3I treatment was started when the tumours reached the volume of 60 mm 3 (day 0). Tumours of untreated mice continued to grow, displaying increasingly high ratios between glucose uptake and tumour volume ( Figure 7D ). In contrast, tumour growth in S3I-treated mice was arrested after three days of treatment, whereas the glucose uptake: tumour volume ratio decreased, which suggests that STAT3 addiction in these cancer cells is based at least partly on STAT3-dependent aerobic glycolysis.
Discussion
The addiction to STAT3 constitutive activity observed in many tumours of distinct origin, where distinct patterns of target genes are induced, suggests that tumour cells rely on STAT3 transcriptional activity for some fundamental biological function shared by most tumours. Additionally, STAT3 constitutive activity is often observed in sites of chronic infl ammation as a result of localised production of IL-6, where it triggers the onset of infl ammation-related cancer, often in conjunction with the transcription factor NF-kB [9] . Thus, STAT3 appears to act at different levels during tumorigenesis, by, i) altering the activity of the pre-tumoural niche; ii) favouring survival and abnormal proliferation during the transformation process and iii) enhancing the invasive and metastatic potential of fully transformed tumour cells.
Our data show indeed that constitutively active STAT3 can enhance breast tumorigenesis downstream of the Neu oncogene via protection from apoptosis and promotion of tumour aggressiveness and metastasis. Interestingly, dissection of the latter indicates that in the C and WT tumour-derived cell lines, the aggressive phenotype could correlate with disrupted distribution of adherent and tight junctions, loss of cortical actin and development of actin stress fi bres, mediated for a good part by the newly identifi ed STAT3 target Cten [13] . Cten is known to mediate EGF-induced migration [12] , to promote cell motility of colon and pancreas cancer cells, and to be overexpressed in late stage epithelial tumours of different types, often correlating with STAT3 constitutive activity [14] . CTEN expression is particularly elevated in the highly aggressive and invasive infl ammatory breast cancers, together with high EGFR and HER2 levels, loss of oestrogen receptor and lymph node metastasis [12] . Thus, our observation of STAT3-mediated CTEN induction by IL-6 suggests that this tensin may be an important mediator in the loop infl ammation-STAT3-migration/metastasis, representing a point of convergence with altered EGFR and/or HER2-mediated signalling, both of which can trigger STAT3 activation. We also show that constitutive STAT3 activity is suffi cient to trigger the switch to aerobic glycolysis. This property can explain why so many biologically distinct tumours are addicted to STAT3 activity for continuous survival and growth. Indeed, most cancer cells share the feature of producing ATP, primarily through aerobic glycolysis, the so-called Warburg effect, thus becoming addicted to high glucose infl uxes [15] . Moreover, enhanced aerobic glycolysis can favour tumoral transformation. The central role of STAT3 in orchestrating this metabolic switch is corroborated by the observation that several STAT3-dependent tumour cell lines display high aerobic glycolysis mediated by STAT3 activity. STAT3 addiction in these cells is indeed linked to STAT3-induced glycolysis, as suggested by the observation that its inhibition down-regulates the glycolysis rate while up-regulating mitochondrial activity prior to leading to apoptotic cell death. Importantly, our data with tumour xenografts support the idea that STAT3 addiction also occurs via the same mechanism in vivo [11] .
The mechanism of this STAT3-dependent metabolic switch appears to be twofold. Aerobic glycolysis is due to the low but continuous induction of HIF-1α mRNA (and protein) mediated by constitutive STAT3 activation. This sustained induction is likely to represent an important functional difference between acute and constitutive STAT3 activity and to allow fast proliferation [16] . However, the down-regulation of mitochondrial activity is HIF-1 α -independent and is likely caused by the observed STAT3-dependent down-regulation of nuclear genes encoding for mitochondrial proteins, which leads to reduced levels of ETC components. The reduced mitochondrial activity may contribute to the decreased ROS accumulation observed in the Stat3 C/C MEFs [11] , which in turn is likely to trigger high resistance of these cells to apoptosis and senescence, two hallmarks of cellular transformation. Although Stat3 C/C MEFs are not transformed, they present features of cells having undergone a fi rst hit in the multi-step transformation process, as suggested by preliminary experiments with spontaneous immortalization [18] .
In conclusion, we show here that STAT3, found constitutively active in the pre-tumoral niche, can induce a metabolic switch that predisposes cells to aberrant survival, enhanced proliferation and, fi nally, tumour transformation. Moreover, enhanced IL-6-induced Cten expression later contributes to tissue infi ltration and metastasis. While not excluding the contribution of many other tumour-specifi c STAT3 target genes, we believe that this represents a unifying view explaining several of the pro-oncogenic activities of this multi-faceted transcription factor.
Materials and methods
Animals, treatments and analysis
Mice were maintained in the transgenic unit of the Molecular Biotechnology Center (University of Turin) under a 12-h lightdark cycle and provided food and water ad libitum . Procedures were conducted in conformity with national and international laws and policies as approved by the Faculty Ethical Committee. The generation of the N-C mice and the analysis of tumour onset were described [10] .
Cell lines
Tumour cell lines were isolated from three different N-C and N-WT mice and cultured in complete medium as described [10] . MEFs were prepared from 13.5-day embryos. Both MEFs and MDA-MB468 (ATCC, Manassas VA, USA) were grown as described [11] . S3I-201 inhibitor was used at a concentration of 100 μ M (MEFs and MDA-MB468) or 200 μ M (C1 cells). Transwell invasion and migration assays were performed as described [10] .
Lung metastasis
1 × 10 5 cells were injected into the tail vein of nude CD1 female mice. Mice were sacrifi ced after 3 weeks, and the lungs fi xed as described [10] . Semiserial sections at 100-μ m intervals were stained with H&E, and neoplastic lesions were counted in blind.
Cten silencing
Cells were plated at a density of 60 % and incubated for 72 h with 1 μ M Accell SMARTpool siRNA (E-054907-00) or with the Accell Non-Targeting siRNA (D-001910-01-05, Dharmacon, Thermo Fisher Scientifi c, Lafayette, CO, USA) according to the manufacturer ' s protocol.
Immunofl uorescence
Immunofl uorescence was performed as previously described [10] and imaged with an Axiovert 200M Zeiss microscope or an AxioObserver-Z1 Zeiss microscope (Carl Zeiss, Inc., Oberkochen, Germany) with the ApoTome system for optical sectioning.
In vitro cell death and senescence assay
Cell death: cells were treated with H 2 O 2 (Sigma Aldrich, St. Louis, MO, USA, 1 mM for 16 h) followed by staining with Annexin-V. Senescence: cells were stained at the indicated times after plating using a Senescence Cells Histochemical Staining Kit (Sigma Aldrich), according to the manufacturer ' s protocol.
Real time-PCR
Total RNA was prepared with the PureLink Micro-to-Midi total RNA Purifi cation System (Invitrogen, Carlsbad, CA, USA). qRT-PCR reactions were performed as previously described [17] using the Universal Probe Library system (Roche Italia, Monza, Italy). The 18S rRNA pre-developed TaqMan assay (Applied Biosystems, Foster City, CA, USA) was used as an internal control.
Glucose and lactate measurements
Glucose or lactate was measured in cell supernatants 3 h after fl uid replacement using a Glucose Assay Kit (Sigma Aldrich) or a Lactate Colorimetric Assay Kit (Abcam, Cambridge, UK). Data were normalised to cell counts.
Lentiviral infection
pLKO vectors carrying either scrambled or shRNA-Hif-1 α sequences (Open Biosystems, Huntsville, AL, USA) were packaged by transfecting 293T cells and used to infect cells for 24 h, followed by puromycin selection for 48 h.
Calcium and ATP measurements
Cells were grown on glass coverslips at 50 % confl uence. For Ca 2 + measurements, cells were infected with the adenovirus expressing the appropriate aequorin chimera, and the light signal was collected and calibrated into [Ca 2 + ] values, as previously described [11] . For measuring mitochondrial ATP, MEFs were transfected with mitochondrial luciferase (mtLuc), and luminescence was measured after 36 h as described [11] .
Respiratory chain activity
MEFs grown in 24-well plates were washed with PBS and PBS containing 5 mM glucose, and 6 μ M resazurine was added and fl uorescence was recorded immediately in a microplate reader (Infi nite M200, Tecan, Austria) at 510-nm excitation and 595-nm emission wavelengths. For control of the threshold activity, cells were preincubated for 15 min with 2 μ M KCN in complete medium, and measurements were performed as described above but in PBS containing 2 μ M KCN. The activity values were normalised to mg of protein.
Small animal PET
PET images were acquired on the positron emission tomograph for small animals, the YAP-(S)PET system, as described [11] . Briefl y, mice were anesthetised by inhalation of 2 % of isofl uorane and intravenously injected with 350 μ Ci ± 50 of [ 
Statistical analysis
Kaplan-Meier survival curves were analysed by Prism4 (GraphPad software); p-values were calculated using the long-rank test. All other p-values were calculated using Student ' s t-test (unpaired, two tailed).
